A recent study showed that low cytosolic and enhanced nuclear TRβ levels are indicators of a poor outcome in breast cancer [116], highlighting the importance of distinguishing between cytosolic and nuclear TRβ abundance, as recognized previously from studies of HeLa liver cancer cells [117]. The gene discussed is THRB; the disease is breast cancer.